**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: January 15, 1975
* Admission Date: March 10, 2023
* Discharge Date: March 20, 2023

**Chief Complaint:**

John Doe, a 48-year-old male, was admitted to the endocrinology unit on March 10, 2023, with a chief complaint of increased thirst and urination over the past two months.

**Medical History:**

The patient has a significant medical history of hypertension, hyperlipidemia, and a 20-pack-year history of smoking. He has not had any previous episodes of diabetes or hypoglycemia.

**Physical Examination:**

Upon admission, the patient's physical examination revealed a blood pressure of 140/90 mmHg, pulse rate of 80 beats per minute, and body mass index (BMI) of 30 kg/m2. The patient had no evidence of diabetic ketoacidosis, but his funduscopic examination revealed mild non-proliferative diabetic retinopathy.

**Laboratory Results:**

The patient's laboratory results revealed the following:

* Fasting plasma glucose (FPG) level: 220 mg/dL (12.2 mmol/L)
* Glycosylated hemoglobin (HbA1C) level: 8.5%
* Random glucose value: 250 mg/dL (13.9 mmol/L)
* Lipid profile: Total cholesterol: 220 mg/dL, HDL cholesterol: 40 mg/dL, LDL cholesterol: 150 mg/dL, triglycerides: 250 mg/dL
* Urine testing for albuminuria: 1+ (30-300 mg/dL)

**Diagnosis:**

Based on the patient's laboratory results and physical examination, the diagnosis of type 2 diabetes was made.

**Treatment:**

The patient was started on metformin 500 mg twice daily, and his diet was modified to focus on whole foods and high-quality carbohydrates. He was also advised to engage in at least 150 minutes of moderate-intensity aerobic exercise per week, with adjustments for hypoglycemia risk.

**Medications:**

* Metformin 500 mg twice daily
* Aspirin 81 mg daily for cardiovascular prevention

**Education:**

The patient was educated on the causes of diabetes, symptoms and signs of hypoglycemia, hyperglycemia, and diabetic complications. He was also instructed on adjusting his insulin doses based on blood glucose levels and carbohydrate intake. The patient was advised to monitor his blood glucose levels regularly and to seek medical attention if he experiences any symptoms of hypoglycemia or hyperglycemia.

**Discharge Instructions:**

The patient was discharged with the following instructions:

* Continue metformin 500 mg twice daily
* Monitor blood glucose levels regularly and adjust insulin doses as needed
* Engage in at least 150 minutes of moderate-intensity aerobic exercise per week
* Monitor for symptoms of hypoglycemia and hyperglycemia and seek medical attention if they occur
* Return for follow-up appointment in one week

**Follow-up:**

The patient is scheduled for a follow-up appointment in one week to monitor his blood glucose levels and adjust his treatment plan as needed.

**Special Instructions:**

The patient was advised to:

* Get vaccinated against Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2
* Schedule regular professional podiatric care to monitor foot health
* Consider medical devices and surgical treatments for obesity, such as sleeve gastrectomy or gastric bypass, if appropriate

**Conclusion:**

John Doe was diagnosed with type 2 diabetes and was treated with metformin and lifestyle modifications. He was educated on the causes of diabetes, symptoms and signs of hypoglycemia, hyperglycemia, and diabetic complications, and was advised to monitor his blood glucose levels regularly and seek medical attention if he experiences any symptoms of hypoglycemia or hyperglycemia. The patient was discharged with a follow-up appointment in one week and was advised to get vaccinated against various diseases and to schedule regular professional podiatric care.